Surendra Kumar Sahoo was just 27 years old when he discovered that he was suffering from end-stage renal disease, which meant ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

Q4 2024 Earnings Call Transcript March 13, 2025 Akebia Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Chronic kidney disease can be a silent killer; thus, we need to know about the causes and symptoms of CKD in advance for ...

March is Kidney Health Month, and in honour of World Kidney Day on Thursday, the the Kidney Foundation of Canada’s southern Alberta branch encouraged residents to take some time to learn their ...

South Texas Health System is honoring World Kidney Day by informing the community on the function of the bean shaped organs ...

Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...

The cost of caring for patients suffering from chronic kidney disease is unsustainable and demands swift action, the Minister of Health stated. Speaking on World Kidney Day today, Kim Wilson said ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...

Researchers investigated the potential association between plasma apolipoprotein M (APOM) levels and the risk of adverse ...